ARTICLE SUMMARY:
Due to cost, stigma, and unpredictable outcomes, access to successful IVF treatment is limited to a small percentage of the more than seven million women in the US who suffer from infertility. Univfy’s rigorously developed, customized prognostics relieve barriers by improving the odds of live births and offering better financial options for patients.
For most people struggling with fertility, in vitro fertilization (IVF) offers the best prospects for a pregnancy that ends in a live birth, enabling the conception of 1% of newborns in the US each year, and cumulatively more than five million babies worldwide. But the field is characterized by wide variance in treatment protocols and high costs with limited success. Most patients fail their first cycle of treatment.
